**Author details**

Felicia Elena Buruiana1 \*, Lamiese Ismail<sup>2</sup> , Federico Ferrari3 and Hooman Soleymani Majd<sup>2</sup>

1 PanBirmingham Gynaecological Cancer Centre, Birmingham, UK

2 Oxford University Hospitals NHS Foundation Trust, Oxford, UK

3 Department of Obstetrics and Gynecology, University of Brescia, Italy

\*Address all correspondence to: f.buruiana@nhs.net

© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**105**

2010) 38-42.

390-396.

*The Role of Ultra-Radical Surgery in the Management of Advanced Ovarian Cancer: State or Art*

[8] Chang S.J., Bristow R.E., Ryu H.S.: Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer, Ann. Surg. Oncol. 19 (13) (Dec 2012) 4059-4067.

[9] Vergote I., Tropé C.G, Amant F., Kristensen G.B., Ehlen T., Johnson N et al.: Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; NCIC Clinical Trials Group, N. Engl. J. Med.

[10] Kommoss S., Rochon J., Harter P.,

Jean-Laurent M., Ferron G., Morice P., Houvenaeghel G., Lecuru F. et al.: Multi-center evaluation of post-

operative morbidity and mortality after optimal cytoreductive surgery for advanced ovarian cancer, PLoS One 7

[12] Soleymani Majd H et al.: Latest developments and techniques in gynaecological oncology surgery, Current opinion in Obstetrics and Gynaecology 27(4), 291-296, https://doi. org/10.1097/gco.0000000000000186.

[13] Cosin J A, Kesterson J P, Olawaiye A B: Staging of Gynaecologic Malignancies Handbook, Society of Gynecologic

[14] Fotopoulou C et al.: Value of Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer: A

European Perspective, Journal of

Ewald-Riegler N., et al.: Prognostic impact of additional extended surgical procedures in advanced-stage primary ovarian cancer, Ann. Surg. Oncol. 17 (1)

363 (2010) 943-953.

(2010 Jan) 279-286.

(7) (2012), e39415.

Oncology, 2014.

[11] Rafii A., Stoeckle E.,

Heitz F., Grabowski J.P.,

*DOI: http://dx.doi.org/10.5772/intechopen.97638*

[2] Reid F: Global Trends in Incidence, Mortality and Survival, The World Ovarian Cancer Coalition Atlas @World

[3] Fotopoulou C, Hall M, Cruickshank D, Gabra H, Ganesan R, Hughes C, Kehoe S,

Gynaecological Cancer Society (BGCS) Epithelial Ovarian / Fallopian Tube / Primary Peritoneal Cancer Guidelines: Recommendations for Practice.

Ovarian Cancer Coalition 2018.

Ledermann J, Morrison J, Naik R, Rolland P, Sundar S: British

[4] Bristow R E, Tomacruz R.S., Armstrong D.K., Trimble E.L., Monts F.J.: Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis, J. Clin. Oncol. 20

[5] Chi D.S., Eisenhauer E.L., Zivanovic O., Sonoda Y.,

[6] Eisenkop S.M, Spirtos N.M., Friedman R.L., Lin W.C., Pisani A.L: Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study, Gynecol. Oncol. 90 (2003)

[7] Chi D.S., O. Zivanovic, K.L.

al:. The incidence of major

procedures during primary

Levinson, V. Kolev, J. Huh, J. Dottino et

complications after the performance of extensive upper abdominal surgical

cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas, Gynecol. Oncol. 119 (1) (Oct

Abu-Rustum N.R, Levine D.A., et al.: Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm, Gynecol. Oncol. 114 (2009) 26-31.

(2002) 1248-1259.

**References**

[1] Ovarian Cancer, Cancerresearchuk.org *The Role of Ultra-Radical Surgery in the Management of Advanced Ovarian Cancer: State or Art DOI: http://dx.doi.org/10.5772/intechopen.97638*
